Tongzhi Wu
TitleCited byYear
Effects of different sweet preloads on incretin hormone secretion, gastric emptying, and postprandial glycemia in healthy humans
T Wu, BR Zhao, MJ Bound, HL Checklin, M Bellon, TJ Little, RL Young, ...
The American journal of clinical nutrition 95 (1), 78-83, 2012
1022012
Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes
RL Young, B Chia, NJ Isaacs, J Ma, J Khoo, T Wu, M Horowitz, CK Rayner
Diabetes 62 (10), 3532-3541, 2013
772013
Effects of rectal administration of taurocholic acid on glucagon‐like peptide‐1 and peptide YY secretion in healthy humans
T Wu, MJ Bound, SD Standfield, B Gedulin, KL Jones, M Horowitz, ...
Diabetes, Obesity and Metabolism 15 (5), 474-477, 2013
742013
Administration of resveratrol for 5 wk has no effect on glucagon-like peptide 1 secretion, gastric emptying, or glycemic control in type 2 diabetes: a randomized controlled trial
SS Thazhath, T Wu, MJ Bound, HL Checklin, S Standfield, KL Jones, ...
The American journal of clinical nutrition 103 (1), 66-70, 2015
512015
Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans
T Wu, MJ Bound, SD Standfield, KL Jones, M Horowitz, CK Rayner
The Journal of Clinical Endocrinology & Metabolism 98 (4), E718-E722, 2013
512013
Dietary effects on incretin hormone secretion
T Wu, CK Rayner, K Jones, M Horowitz
Vitamins & Hormones 84, 81-110, 2010
452010
Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity?
T Wu, SS Thazhath, MJ Bound, KL Jones, M Horowitz, CK Rayner
Diabetes research and clinical practice 106 (1), e3-e6, 2014
432014
A protein preload enhances the glucose-lowering efficacy of vildagliptin in type 2 diabetes
T Wu, TJ Little, MJ Bound, M Borg, X Zhang, CF Deacon, M Horowitz, ...
Diabetes Care 39 (4), 511-517, 2016
402016
Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and†…
T Wu, J Ma, MJ Bound, H Checklin, CF Deacon, KL Jones, M Horowitz, ...
Diabetes 63 (8), 2776-2787, 2014
402014
Incretins
T Wu, CK Rayner, M Horowitz
Metabolic Control, 137-171, 2015
392015
Gut motility and enteroendocrine secretion
T Wu, CK Rayner, RL Young, M Horowitz
Current opinion in pharmacology 13 (6), 928-934, 2013
392013
Artificial sweeteners have no effect on gastric emptying, glucagon-like peptide-1, or glycemia after oral glucose in healthy humans
T Wu, MJ Bound, SD Standfield, M Bellon, RL Young, KL Jones, ...
Diabetes care 36 (12), e202-e203, 2013
382013
Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes
T Wu, MJ Bound, BR Zhao, SD Standfield, M Bellon, KL Jones, ...
Diabetes Care 36 (7), 1913-1918, 2013
372013
Whey protein: The “whey” forward for treatment of type 2 diabetes?
LE Mignone, T Wu, M Horowitz, CK Rayner
World journal of diabetes 6 (14), 1274, 2015
332015
Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in†…
J Chang, T Wu, JR Greenfield, D Samocha-Bonet, M Horowitz, CK Rayner
Diabetes Care 36 (8), 2262-2265, 2013
312013
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2†…
SS Thazhath, CS Marathe, T Wu, J Chang, J Khoo, P Kuo, HL Checklin, ...
Diabetes 65 (1), 269-275, 2016
282016
Metformin reduces the rate of small intestinal glucose absorption in type 2 diabetes
T Wu, C Xie, H Wu, KL Jones, M Horowitz, CK Rayner
Diabetes, Obesity and Metabolism 19 (2), 290-293, 2017
212017
New insights into the anti-diabetic actions of metformin: from the liver to the gut
T Wu, M Horowitz, CK Rayner
Expert review of gastroenterology & hepatology 11 (2), 157-166, 2017
162017
Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut–incretin axis response in healthy males
T Wu, SS Thazhath, CS Marathe, MJ Bound, KL Jones, M Horowitz, ...
Nutrition & diabetes 5 (5), e156, 2015
122015
Glucose absorption in small intestinal diseases
SS Thazhath, T Wu, RL Young, M Horowitz, K Christopher
Expert Review of Gastroenterology & Hepatology Downloaded from†…, 2014
122014
The system can't perform the operation now. Try again later.
Articles 1–20